Skip to main content
. 2020 Jul 23;21:900–915. doi: 10.1016/j.omtn.2020.07.025

Table 1.

Expression of LCP1 and miR-135a-5p According to Patients’ Clinical Features

Characteristics Number LCP1 Expression
p Value miR-135a-5p Expression
p Value
High Group Low Group High Group Low Group
Age (Years)
 <18 25 10 15 0.41 11 14 0.80
 ≥18 15 8 7 6 9
Gender
 Female 22 12 10 0.95 9 13 0.57
 Male 18 10 8 9 9
Location
 Femur/tibia 33 16 17 0.79 14 19 0.48
 Elsewhere 7 3 4 4 3
TNM Stage
 I 19 8 11 0.028a 13 6 0.027a
 II/III 21 16 5 7 14
Tumor Size (cm)
 <5 18 7 11 0.031a 12 6 0.028a
 ≥5 22 16 6 7 15
Metastasis
 Yes 16 12 4 0.02a 5 11 0.028a
 No 24 9 15 16 8

Expression levels of LCP1 and miR-135a-5p were correlated with tumor TNM stage and metastasis, according to the clinical features of 40 patients.

a

p < 0.05 (chi-square test).